Basics Revolution Medicines, Inc. IPO Date: February 13, 2020 Sector: Healthcare Industry: Biotech Market Cap: $15.4B Activated in VL: True Average Daily Range Avg Daily Range: $0.82 | 2.65% Avg Daily Range (30 D): $1.18 | 1.78% Avg Daily Range (90 D): $0.90 | 1.77% Institutional Daily Volume Avg Daily Volume: .89M Avg Daily Volume (30 D): 1.96M Avg Daily Volume (90 D): 1.8M Trade Size Avg Trade Size (Sh.): 69 Avg Trade Size (Sh.) (30 D): 61 Avg Trade Size (Sh.) (90 D): 63 Institutional Trades Total Inst.Trades: 5,052 Avg Inst. Trade: $3.19M Avg Inst. Trade (30 D): $3.74M Avg Inst. Trade (90 D): $3.77M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $6.22M Avg Closing Trade (30 D): $14.99M Avg Closing Trade (90 D): $11.84M Avg Closing Volume: 182.81K     News Sep 29, 2025 @ 1:00 PM Revolution Medicines Announces Key Leadership Addi... Source: Revolution Medicines Aug 26, 2025 @ 11:00 AM Tango Therapeutics to Participate in the 2025 Cant... Source: Barbara Weber, M.D. Aug 6, 2025 @ 12:25 AM Tango (TNGX) Q2 Revenue Drops 52% Source: Na Jun 27, 2025 @ 11:00 AM Tango Therapeutics Announces First Patient Dosed i... Source: Tango Therapeutics May 27, 2025 @ 1:00 PM rEvolution Appoints Brian Gabriel as Vice Presiden... Source: Globe Newswire Financials   TTM Q3 2025 Q2 2025 Basic EPS $-5.19 $-1.61 $-1.31 Diluted EPS $-5.19 $-1.61 $-1.31 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -960.98M $ -305.21M $ -247.79M Operating Income / Loss $ -1037.05M $ -315.27M $ -264.71M Cost of Revenue $ $ $ Net Cash Flow $ 18.15M $ -184.05M $ 69.1M PE Ratio